News from us and our partners

Tags

Topics

0 results

News
26 June, 2024
Crescendo Biologics announces that Zai Lab has initiated a global Phase 2 clinical trial evaluating ZL-1102 (Humabody®, CB001) as a topical treatment for psoriasis
News
18 June, 2024
BrightHeart appoints Michael Butchko as Chairman of the Board
News
17 June, 2024
Meiogenix hires Ricardo Garcia de Alba as CEO
News
12 June, 2024
NodThera meets primary endpoint in Phase 1b/2a trial
News
12 June, 2024
T-Therapeutics appoints Dr. David Hung as Chairman
News
12 June, 2024
Danone, DMC, Michelin and Crédit Agricole Centre France join forces to create a cutting-edge biotechnology platform
News
7 June, 2024
SafeHeal's Colovac wins FDA Breakthrough Device designation
News
5 June, 2024
Moon Surgical receives second FDA clearance, covering its commercial Maestro™ surgical robotics system
News
4 June, 2024
Afyren provides business update on its Afyren Neoxy plant
News
3 June, 2024
HighLife receives IDE approval to initiate US pivotal clinical study for treatment of mitral regurgitation
News
3 June, 2024
GenSight Biologics appoints William Monteith to its Board of Directors
News
31 May, 2024
Johnson & Johnson completes acquisition of Shockwave Medical
News
28 May, 2024
Asahi Kasei to acquire Calliditas Therapeutics AB to accelerate growth as a global healthcare company
News
28 May, 2024
Elicit Plant accelerates its international expansion in response to climate change and challenges in the agricultural sector
News
28 May, 2024
Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei Corporation
News
28 May, 2024
NodThera announces appointment of Daniel Swisher as Chief Executive Officer

Crescendo Biologics announces that Zai Lab has initiated a global Phase 2 clinical trial evaluating ZL-1102 (Humabody®, CB001) as a topical treatment for psoriasis

BrightHeart appoints Michael Butchko as Chairman of the Board

Meiogenix hires Ricardo Garcia de Alba as CEO

NodThera meets primary endpoint in Phase 1b/2a trial

T-Therapeutics appoints Dr. David Hung as Chairman

Danone, DMC, Michelin and Crédit Agricole Centre France join forces to create a cutting-edge biotechnology platform

SafeHeal's Colovac wins FDA Breakthrough Device designation

Moon Surgical receives second FDA clearance, covering its commercial Maestro™ surgical robotics system

Afyren provides business update on its Afyren Neoxy plant

HighLife receives IDE approval to initiate US pivotal clinical study for treatment of mitral regurgitation

GenSight Biologics appoints William Monteith to its Board of Directors

Johnson & Johnson completes acquisition of Shockwave Medical

Asahi Kasei to acquire Calliditas Therapeutics AB to accelerate growth as a global healthcare company

Elicit Plant accelerates its international expansion in response to climate change and challenges in the agricultural sector

Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei Corporation

NodThera announces appointment of Daniel Swisher as Chief Executive Officer